Notice2023-01953

Center for Scientific Review; Notice of Closed Meetings

Primary source

Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.

Published
January 31, 2023

Issuing agencies

Health and Human Services DepartmentNational Institutes of Health

Full Text

<html>
<head>
<title>Federal Register, Volume 88 Issue 20 (Tuesday, January 31, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 20 (Tuesday, January 31, 2023)]
[Notices]
[Pages 6288-6289]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-01953]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; PAR Panel: Research on Current Topics in Alzheimer's Disease 
and its Related Dementias.
    Date: February 23-24, 2023.
    Time: 9 a.m. to 6 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Mei Qin, Ph.D., MD, Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 5213, Bethesda, MD 20892, 301-875-2215, 
<a href="/cdn-cgi/l/email-protection#65140c0b08000c250616174b0b0c0d4b020a13"><span class="__cf_email__" data-cfemail="05746c6b68606c456676772b6b6c6d2b626a73">[email&#160;protected]</span></a>.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Antiviral Drug Discovery and Molecular Pharmacology.
    Date: February 23, 2023.
    Time: 9:30 a.m. to 8 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Shinako Takada, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Bethesda, MD 20892, 301-827-5997, 
<a href="/cdn-cgi/l/email-protection#d7a4bfbeb9b6bcb8f9a3b6bcb6b3b697b9bebff9b0b8a1"><span class="__cf_email__" data-cfemail="7f0c1716111e1410510b1e141e1b1e3f11161751181009">[email&#160;protected]</span></a>.

    Name of Committee: Brain Disorders and Clinical Neuroscience 
Integrated Review Group; Acute Neural Injury and Epilepsy Study 
Section.
    Date: February 23-24, 2023.
    Time: 9:30 a.m. to 6 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Paula Elyse Schauwecker, Ph.D., Scientific 
Review Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 5201, Bethesda, MD 20892, 301-
760-8207, <a href="/cdn-cgi/l/email-protection#5d2e3e353c282a383e36382f2d381d3e2e2f73333435733a322b"><span class="__cf_email__" data-cfemail="7201111a13070517111917000217321101005c1c1b1a5c151d04">[email&#160;protected]</span></a>.

    Name of Committee: Infectious Diseases and Immunology B 
Integrated Review Group; Immunity and Host Defense Study Section.
    Date: February 23-24, 2023.
    Time: 9:30 a.m. to 8 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Alok Mulky, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 4203, Bethesda, MD 20892, (301) 435-3566, 
<a href="/cdn-cgi/l/email-protection#90fde5fcfbe9f1d0fdf1f9fcbefef9f8bef7ffe6"><span class="__cf_email__" data-cfemail="deb3abb2b5a7bf9eb3bfb7b2f0b0b7b6f0b9b1a8">[email&#160;protected]</span></a>.


[[Page 6289]]


    Name of Committee: Interdisciplinary Molecular Sciences and 
Training Integrated Review Group; Emerging Imaging Technologies in 
Neuroscience Study Section.
    Date: February 23-24, 2023.
    Time: 9:30 a.m. to 7 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Sharon S. Low, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 5104, MSC 7846, Bethesda, MD 20892, 301-237-
1487, <a href="/cdn-cgi/l/email-protection#fb97948c8888bb988889d5959293d59c948d"><span class="__cf_email__" data-cfemail="6c00031b1f1f2c0f1f1e42020504420b031a">[email&#160;protected]</span></a>.

    Name of Committee: Oncology 1-Basic Translational Integrated 
Review Group; Gene Regulation in Cancer Study Section.
    Date: February 23-24, 2023.
    Time: 10 a.m. to 8 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Manzoor A. Zarger, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 6208, MSC 7804, Bethesda, MD 
20892, (301) 435-2477, <a href="/cdn-cgi/l/email-protection#2953485b4e4c5b4448694a5a5b07474041074e465f"><span class="__cf_email__" data-cfemail="dba1baa9bcbea9b6ba9bb8a8a9f5b5b2b3f5bcb4ad">[email&#160;protected]</span></a>.

    Name of Committee: Integrative, Functional and Cognitive 
Neuroscience Integrated Review Group; Neuroscience of Interoception 
and Chemosensation Study Section.
    Date: February 23-24, 2023.
    Time: 10 a.m. to 8 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Myongsoo Matthew Oh, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 1011F, Bethesda, MD 20892, (301) 
435-1042, <a href="/cdn-cgi/l/email-protection#caa5a2a7a78aa9b9b8e4a4a3a2e4ada5bc"><span class="__cf_email__" data-cfemail="452a2d2828052636376b2b2c2d6b222a33">[email&#160;protected]</span></a>.

    Name of Committee: Endocrinology, Metabolism, Nutrition and 
Reproductive Sciences Integrated Review Group; Nutrition and 
Metabolism in Health and Disease Study Section.
    Date: February 23-24, 2023.
    Time: 10 a.m. to 8 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Jonathan Michael Peterson, Ph.D., Scientific 
Review Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 867-5309, 
<a href="/cdn-cgi/l/email-protection#214b4e4f405549404f0f5144554453524e4f614f48490f464e57"><span class="__cf_email__" data-cfemail="076d686966736f666929776273627574686947696e6f29606871">[email&#160;protected]</span></a>.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; PAR-19-367: Maximizing Investigators' Research Award.
    Date: February 23-24, 2023.
    Time: 10 a.m. to 8 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Brian Paul Chadwick, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 594-3586, 
<a href="/cdn-cgi/l/email-protection#5a39323b3e2d333931382a1a39292874343332743d352c"><span class="__cf_email__" data-cfemail="66050e0702110f050d04162605151448080f0e48010910">[email&#160;protected]</span></a>.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Special Topics: Neuroimaging Technologies.
    Date: February 24, 2023.
    Time: 10 a.m. to 8 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Raj K. Krishnaraju, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 6190, MSC 7804, Bethesda, MD 
20892, (301) 435-1047, <a href="/cdn-cgi/l/email-protection#b3d8d8c1dac0dbddd2f3d0c0c19ddddadb9dd4dcc5"><span class="__cf_email__" data-cfemail="d1babaa3b8a2b9bfb091b2a2a3ffbfb8b9ffb6bea7">[email&#160;protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

    Dated: January 25, 2023.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-01953 Filed 1-30-23; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Indexed from Federal Register on January 31, 2023.

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.